Are you a start-up or small biotech company with less than 25 employees conducting innovative research and development with strong commercial potential? If yes, you may be one of the participants chosen to present in front of the invited large pharma companies.

To apply to this event, CEOs must provide a 2-page executive summary and a short slide deck (max 5 slides) to describe their disruptive technology, target indications and differentiation features. Documents must be submitted no later than Friday March 1st, 2019, 5PM at the following email address: